Home > News&Events > Research Highlights
 
 
2014.03 Research Highlights
 
Yu, Ja-Young 2014-03-26 17:08:21
sinx0yjy@naver.com 2014-04-16 16:49:00
 
 
"Reciprocal Activation of CD4+ T Cells and Synovial Fibroblasts by Stromal Cell-Derived Factor 1 Promotes RANKL Expression and Osteoclastogenesis in Rheumatoid Arthritis.”, Kim HR1, Kim KW, Kim BM, Jung HG, Cho ML, Lee SH., Arthritis Rheumatol., 2014.3; 66(3):538-48. (SCI, IF: 7.48)

<Abstract>

OBJECTIVE:
Stromal cell-derived factor 1 (SDF-1) is a chemokine that is involved in the bone-destructive process in rheumatoid arthritis (RA) and bony metastasis in malignancy. This study was undertaken to determine the role and mechanism of SDF-1 in RA-associated osteoclastogenesis.

METHODS:
The expression of SDF-1, tumor necrosis factor α (TNFα), and RANKL in RA synovial tissue was analyzed using confocal microscopy. After synovial fibroblasts and CD4+ T cells were treated with SDF-1, RANKL messenger RNA expression was determined by real-time and reverse transcription polymerase chain reaction. Osteoclastogenesis was assessed by counting tartrate-resistant acid phosphatase-positive multinucleated cells in CD14+ monocytes cultured with SDF-1 in the presence of anticytokine antibodies or signal inhibitors and in monocytes cocultured with SDF-1-pretreated synovial fibroblasts and CD4+ T cells.

RESULTS:
RANKL, TNFα, and SDF-1 were coexpressed in the lining and sublining of RA synovium. SDF-1 stimulated RANKL expression in RA synovial fibroblasts and CD4+ T cells, and TNFα inhibition reduced this stimulation. When monocytes isolated from human peripheral blood were cultured with SDF-1, they were differentiated into osteoclasts in the absence of RANKL. Monocytes were also differentiated into osteoclasts when they were cocultured with SDF-1-pretreated synovial fibroblasts or CD4+T cells; however, this osteoclastogenesis was reduced by TNFα inhibition.

CONCLUSION:
Our findings indicate that SDF-1 induces osteoclastogenesis directly and indirectly via up-regulating RANKL expression in RA synovial fibroblasts and CD4+ T cells, and that this is mediated by TNFα. The axis of SDF-1 and RANKL is a potential therapeutic target for RA-associated bone destruction.


6 2017.07 Research Highlights IBST 2017-08-21 338
5 2014.05 Research Highlights Yu, Ja-Young 2014-05-28 947
4 2014.04 Research Highlights Yu, Ja-Young 2014-04-25 983
3 2014.03 Research Highlights Yu, Ja-Young 2014-03-26 912
2 2014.02 Research Highlights Yu, Ja-Young 2014-03-26 1,026
1 2013.12 Research Highlights Yu, Ja-Young 2014-03-26 785